Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting

• DOI: 10.3802/jgo.2024.35.e85
• Publication Date: 2024-04-22T06:56:42Z
• Authors: Wichai Termrungru...; Nipon Khemapech; Apichai Vasuratna; Piyalamporn Havanond; Tanitra Tantitamit
• Keywords: Bivalent (engine); Middle income country

To compare the health impact and economic benefits among individuals who did not receive human papillomavirus (HPV) vaccine to those received a single dose, or 2 doses. The comparison was stratified by 4 types of in conjunction with primary HPV screening low/middle-income country setting.